Overview
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Status:
Recruiting
Recruiting
Trial end date:
2021-12-01
2021-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine how a non-opioid pain control regimen, administered before and during surgery, will affect postoperative pain control and total opioid consumption in head and neck cancer participants undergoing cancer surgery with free flap reconstruction.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Case Comprehensive Cancer CenterTreatments:
Acetaminophen
Celecoxib
Gabapentin
Ketamine
Lidocaine
Criteria
Inclusion Criteria:- Undergoing head & neck free flap reconstruction at the Cleveland Clinic Main Campus
- Subjects must have the ability to understand and the willingness to sign a written
informed consent document.
Exclusion Criteria:
- History of allergy to lidocaine, ketamine, acetaminophen, gabapentin, and/or celecoxib
- History of allergic reactions attributed to compounds of similar chemical or biologic
composition to Ketamine, Lidocaine or other agents used in this study
- Subjects receiving any other investigational agents
- Inadequate renal function (serum creatinine ≥ 2 mg/dl) within 30 days
- Inadequate hepatic function (total bilirubin ≥ 2 x the institutional ULN and/or AST or
ALT ≥3 x the institutional ULN) within 30 days
- Known or suspected history of illicit drug abuse (including opioids but excluding
tobacco and EtOH) within the past 6 months
- Pregnancy
- Contraindication to lidocaine (heart block, heart failure with EF < 30%) as determined
by history of Congestive Heart Failure, or as determined by preoperative evaluation
for surgical clearance
- In the opinion of the investigator, subjects with uncontrolled intercurrent illness
including, but not limited to ongoing or active infection, symptomatic congestive
heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric
illness/social situations that would limit compliance with study requirements